These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 29571131)
1. Nuclear magnetic resonance spectroscopy as a tool for the quantitative analysis of water and ions in pharmaceuticals: Example of heparin. Monakhova YB; Diehl BWK J Pharm Biomed Anal; 2018 May; 154():332-338. PubMed ID: 29571131 [TBL] [Abstract][Full Text] [Related]
2. Nuclear magnetic resonance spectroscopy as an elegant tool for a complete quality control of crude heparin material. Monakhova YB; Diehl BWK J Pharm Biomed Anal; 2022 Sep; 219():114915. PubMed ID: 35777175 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulant activity of porcine heparin: Structural-property relationship and semi-quantitative estimation by nuclear magnetic resonance (NMR) spectrometry. Monakhova YB; Fareed J; Yao Y; Diehl BWK J Pharm Biomed Anal; 2019 Sep; 174():639-643. PubMed ID: 31279893 [TBL] [Abstract][Full Text] [Related]
4. Characterization of di- and monosulfated, unsaturated heparin disaccharides with terminal N-sulfated 1,6-anhydro-beta-D-glucosamine or N-sulfated 1,6-anhydro-beta-D-mannosamine residues. Mascellani G; Guerrini M; Torri G; Liverani L; Spelta F; Bianchini P Carbohydr Res; 2007 May; 342(6):835-42. PubMed ID: 17280651 [TBL] [Abstract][Full Text] [Related]
5. Novel method for the determination of average molecular weight of natural polymers based on 2D DOSY NMR and chemometrics: Example of heparin. Monakhova YB; Diehl BWK; Do TX; Schulze M; Witzleben S J Pharm Biomed Anal; 2018 Feb; 149():128-132. PubMed ID: 29112901 [TBL] [Abstract][Full Text] [Related]
6. Multinuclear NMR screening of pharmaceuticals using standardization by Monakhova YB; Diehl BWK J Pharm Biomed Anal; 2022 Feb; 209():114530. PubMed ID: 34915326 [TBL] [Abstract][Full Text] [Related]
7. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects. Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650 [TBL] [Abstract][Full Text] [Related]
8. A heparin-like compound isolated from a marine crab rich in glucuronic acid 2-O-sulfate presents low anticoagulant activity. Andrade GP; Lima MA; de Souza Junior AA; Fareed J; Hoppensteadt DA; Santos EA; Chavante SF; Oliveira FW; Rocha HA; Nader HB Carbohydr Polym; 2013 Apr; 94(1):647-54. PubMed ID: 23544586 [TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry. Camara JE; Satterfield MB; Nelson BC J Pharm Biomed Anal; 2007 Apr; 43(5):1706-14. PubMed ID: 17275239 [TBL] [Abstract][Full Text] [Related]
10. Effect of solvent and counterions upon structure and NMR spin-spin coupling constants in heparin disaccharide. Hricovíni M J Phys Chem B; 2011 Feb; 115(6):1503-11. PubMed ID: 21254757 [TBL] [Abstract][Full Text] [Related]
11. Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins. Mauri L; Boccardi G; Torri G; Karfunkle M; Macchi E; Muzi L; Keire D; Guerrini M J Pharm Biomed Anal; 2017 Mar; 136():92-105. PubMed ID: 28068519 [TBL] [Abstract][Full Text] [Related]
12. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis. Dietrich CP; Paiva JF; Castro RA; Chavante SF; Jeske W; Fareed J; Gorin PA; Mendes A; Nader HB Biochim Biophys Acta; 1999 Aug; 1428(2-3):273-83. PubMed ID: 10434045 [TBL] [Abstract][Full Text] [Related]
13. Non-Anticoagulant Low Molecular Weight Heparins for Pharmaceutical Applications. Ouyang Y; Yu Y; Zhang F; Chen J; Han X; Xia K; Yao Y; Zhang Z; Linhardt RJ J Med Chem; 2019 Jan; 62(2):1067-1073. PubMed ID: 30608147 [TBL] [Abstract][Full Text] [Related]
14. Improving reliability of chemometric models for authentication of species origin of heparin by switching from 1D to 2D NMR experiments. Monakhova YB; Fareed J; Yao Y; Diehl BWK J Pharm Biomed Anal; 2018 May; 153():168-174. PubMed ID: 29494889 [TBL] [Abstract][Full Text] [Related]
15. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market. Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266 [TBL] [Abstract][Full Text] [Related]
16. Authentication of animal origin of heparin and low molecular weight heparin including ovine, porcine and bovine species using 1D NMR spectroscopy and chemometric tools. Monakhova YB; Diehl BWK; Fareed J J Pharm Biomed Anal; 2018 Feb; 149():114-119. PubMed ID: 29112899 [TBL] [Abstract][Full Text] [Related]
17. (1)H NMR signal at 2.10 ppm in the spectrum of KMnO(4)-bleached heparin sodium: identification of the chemical origin using an NMR-only approach. Kellenbach E; Sanders K; Michiels PJ; Girard FC Anal Bioanal Chem; 2011 Jan; 399(2):621-8. PubMed ID: 21069304 [TBL] [Abstract][Full Text] [Related]
18. NMR of heparin API: investigation of unidentified signals in the USP-specified range of 2.12-3.00 ppm. Lee SE; Chess EK; Rabinow B; Ray GJ; Szabo CM; Melnick B; Miller RL; Nair LM; Moore EG Anal Bioanal Chem; 2011 Jan; 399(2):651-62. PubMed ID: 20949261 [TBL] [Abstract][Full Text] [Related]
19. (1)H nuclear magnetic resonance spectroscopic analysis for determination of glucuronic and iduronic acids in dermatan sulfate, heparin, and heparan sulfate. Sudo M; Sato K; Chaidedgumjorn A; Toyoda H; Toida T; Imanari T Anal Biochem; 2001 Oct; 297(1):42-51. PubMed ID: 11567526 [TBL] [Abstract][Full Text] [Related]